during the past decade , advances in the treatment of childhood acute lymphoblastic leukemia ( all ) have continued , largely due to improved disease-free survival of poor-prognosis subgroups , improved sanctuary therapy , shortening of therapy duration , and salvage of relapsed patients with better chemotherapy regimens and with bone marrow transplantation .
C0087111
therapy
C0005961
bone marrow transplantation